Flavonoids from the Brazilian plant Croton betulaster inhibit the growth of human glioblastoma cells and induce apoptosis  by Coelho, Paulo Lucas Cerqueira et al.
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a  b  s  t  r  a  c  t
This study  investigated  the effects  of the  ﬂavonoids  5-hydroxy-7,4′-dimethoxyﬂavone,  casticin,  and  pen-
duletin,  isolated  from  Croton  betulaster  Müll  Arg.,  Euphorbiaceae,  a plant  utilized  in popular  medicine  in
Brazil,  on  the growth  and viability  of  the  human  glioblastoma  cell  line  GL-15.  We  observed  that  5-hydroxy-
7,4′-dimethoxyﬂavone  and  casticin  were  not  toxic  to  GL-15  cells  after  24  h  of exposure.  However,  casticin
and  penduletin  inhibited  the  metabolic  activity  of  glioblastoma  cells  signiﬁcantly  at  a concentration
of  10  M (p ≤ 0.05).  Flavonoids  casticin  and  penduletin  also  induced  a  signiﬁcant  and  dose-dependent
growth  inhibition  beginning  at 24  h  of  exposure,  and  the  most  potent  ﬂavonoid  was  penduletin.  It  was
also  observed  that  penduletin  and  casticin  induced  an  enlargement  of  the cell body  and a reduction  of  cel-
lular  processes,  accompanied  by changes  in  the  pattern  of expression  of the  cytoskeletal  protein  vimentin.
Signs  of  apoptosis,  such  as the  externalization  of membrane  phosphatidyl  serine  residues,  nuclear  con-
densation,  and  fragmentation,  were  also  detected  in cells  treated  with  50–100  M ﬂavonoids.  Our  results
indicate  that  ﬂavonoids  extracted  from  C. betulaster  present  antitumoral  activity  to  glioblastoma  cells,
with  penduletin  proving  to  be the  most  potent  of the  tested  ﬂavonoids.  Our  results  also  suggest  that  these
molecules  may  be promising  supplementary  drugs  for glioblastoma  treatment.
©  2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Croton betulaster Müll. Arg., Euphorbiaceae, is a shrub found
n the northern part of the Cadeia do Espinhac¸ o, from Grão
ogol to the Serra do Sincorá in the Chapada Diamantina, Bahia,
razil (Stannard, 1995). C. betulaster is a plant used in popular
edicine to treat diabetes and diarrhea and is also known for
ts cicatrizing, anti-inﬂammatory, anti-malarial, anti-carcinogenic,
nthelmintic and insecticidal properties. Barbosa et al. (2003) iso-
ated ﬂavonoids with different degrees of methylation from C.
etulaster. Flavonoids are polyphenolic compounds of natural ori-
in that are especially abundant in ﬂowers and fruits and have
aised interest in scientiﬁc community (Bruneton, 1991) due to
heir biological activities. These molecules have several functions
∗ Corresponding author.
E-mails: costasl@ufba.br, silvia.lima@pq.cnpq.br (S.L. Costa).
http://dx.doi.org/10.1016/j.bjp.2015.05.013
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editorain plants: protecting leaves from ultra violet rays, inducing growth
and attracting pollinators. Several studies have demonstrated that
ﬂavonoids have antioxidant, analgesic, antibacterial, antifungal,
anti-inﬂammatory, antiviral, antitumor, antiallergic, and antipar-
asitic activities (Friedman, 2007; Ozcelik et al., 2006; Ye et al.,
2007; Uyana, 2007; Bukhari et al., 2007; Cai et al., 2006; Pantev
et al., 2006; Roy et al., 2007; Kawai et al., 2007; Mead and McNair,
2006). Recent studies demonstrated that ﬂavonoids can cross the
blood–brain barrier, especially when they are highly methylated
(Youdim et al., 2003, 2004; Walle et al., 2007; Xu et al., 2007).
Glioblastoma multiforme (GBM) is the most aggressive and most
frequent primary tumor of the central nervous system, comprising
approximately 50% of cerebral gliomas. They are highly invasive,
rapidly proliferating tumors that develop in cerebral hemispheres
and present a poor prognosis. Surgical removal of the tumor con-
stitutes the ﬁrst line of therapy. Unfortunately, glioblastoma cells
are highly mobile and also inﬁltrate the surrounding tissues. Thus,
in most cases, surgery has to be followed by radiation therapy.
 Ltda. All rights reserved.
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tandard chemotherapy consists in alkylating drugs, such as car-
oplatin, carmustine, fotemustine or temozolomide. Despite recent
dvances in these therapies, the median survival time for glioblas-
oma patients continues to be approximately 12 month. Agents
uch as tamoxifen, selenium, retinoids and cytokines have been
roposed, but their effects remain a topic of discussion (Defer
t al., 1997; Chambaut-Guérin et al., 2000; Costa et al., 2001;
ooprai et al., 2007). New natural compounds with anti-tumor
otential may  offer an alternative to the traditional cytotoxic
reatments. In this study, we used a model the human high prolife-
ative glioblastoma cell line GL-15 to investigate the effects of the
avonoids 5-hydroxy-7,4′-dimethoxyﬂavone (dimethoxyﬂavone),
′,4′-dihydroxy-3,6,7-trimethoxyﬂavone (penduletin), and 5,3′-
ihydroxy-3,6,7,4′ tetramethoxyﬂavone (casticin) isolated from C.
etulaster Müll. Arg. on the viability, proliferation and induction of
orphological changes on malignant glioma cells.
aterials and methods
xtraction, isolation and characterization of ﬂavonoids
The ﬂavonoids 5-hydroxy-7,4′-dimethoxyﬂavone (dimethoxy-
avone), 5′,4′-dihydroxy-3,6,7-trimethoxyﬂavone (penduletin),
nd 5,3′-dihydroxy-3,6,7,4′-tetramethoxyﬂavone (casticin) were
btained from the leaves of Croton betulaster Müll. Arg., Euphor-
iaceae (Barbosa et al., 2003). C. betulaster is a shrub found in
he northern part of the Cadeia do Espinhac¸ o, from Grão Mogol
o the Serra do Sincorá in the Chapada Diamantina, Bahia, Brazil
Cordeiro, 1995). Aerial parts of C. betulaster were collected in
une 1997, from Palmeiras, Chapada Diamantina, Bahia, Brazil,
nd were identiﬁed by Maria Lenise S. Guedes from the Insti-
uto de Biologia, UFBA. A voucher specimen has been deposited
n the herbarium of the Federal University of Bahia (ALCB number
31762), Brazil. The air-dried leaves (600 g) of C. betulaster were
xtracted with hexane, followed by dichloromethane and ﬁnally
ethanol. Successive silica gel columns (CC) of dichloromethane
xtracted from the leaves (45 g) using increasing amounts of EtOAc
n hexane yielded casticin (450 mg)  and penduletin (81 mg). The
ethanol extract was dissolved in MeOH–H2O (9:1) and parti-
ioned against hexane, dichloromethane, AcOEt and n-butanol. The
cOEt-soluble portion of the methanol extract chromatographed
n a silica gel CC and eluted with a gradient of hexane–EtOAc
ielded 5-hydroxy-7,4′-dimethoxyﬂavone (25 mg). The ﬂavonoid
tructures were identiﬁed by an NMR  data analysis and compared
ith the data reported in the literature.
ell culture and treatments
The GL-15 cell line was derived from human glioblastoma multi-
orme and was  cultured as previously described (Chambaut-Guérin
t al., 2000; Costa et al., 2001). Brieﬂy, cells were grown until
onﬂuence in the cell culture dishes (TPP) in Dulbecco’s Modiﬁed
agle’s Medium (DMEM, Cultilab, SP, Brazil) and were supple-
ented with 100 UI/ml penicillin G, 100 g/ml streptomycin, 7 mM
lucose, 2 mM l-glutamine, 0.011 g/l pyruvate, and 10% fetal calf
erum (Gibco, Grand Island, NY) in a humidiﬁed atmosphere with
% CO2 at 37 ◦C. The ﬂavonoids from C. betulaster were dissolved in
imethyl sulfoxide (DMSO, Sigma, St. Louis, MO)  at a concentration
f 20 mM and stored in the dark at −20 ◦C. The ﬂavonoids were then
issolved in medium at ﬁnal concentrations of 10, 50 and 100 M
nd incubated for 24–72 h. Control cells were treated with the same
olume of DMSO, not exceeding 0.5%, and did not show any signif-
cant effect within the parameters analyzed compared to cultures
ot exposed to this solvent; therefore, these cells were adopted as
he negative control. Farmacognosia 26 (2016) 34–43 35
Cell viability – MTT test
The ﬂavonoids’ effect on GL-15 cell viability was  tested
using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT; Sigma, St. Louis, MO)  test after 24 and 72 h expo-
sure in 96-well plates (TPP Switzerland, 1 × 104 cells/well). The cell
viability was  quantiﬁed by the conversion of yellow MTT  by mito-
chondrial dehydrogenases of living cells to purple MTT  formazan.
Three hours before the end of the exposure duration, the medium
was removed and replaced with DMEM without supplementation
containing MTT  (1 mg/ml). Afterwards, 100 l/well of a buffer con-
taining 20% SDS and 50% DMF, pH 4.7, was added, and the plate
was kept for 12 h at 37 ◦C for complete dissolution of the formazan
crystals. The optic absorbency of each sample was measured at a
wavelength of 560 nm using a BIO-RAD 550PLUS spectrophotome-
ter (Hercules, CA). Four replicate wells were used for each analysis.
The results were determined as the average ± standard deviation
(SD) and expressed as percentages of the control group viability.
Assay of proliferation – thymidine incorporation
The effect of ﬂavonoids from C. betulaster on cellular prolifera-
tion was  studied by measuring the incorporation of 2-(methyl-3H)
thymidine (1 Ci/ml, Amersham). In brief, the cells were cultured
into 96-well plates (TPP, Switzerland) (1 × 104 cells/well) and incu-
bated in four replicates with 1–100 M ﬂavonoids or 0.5% DMSO
(control) for 24 and 72 h. The cells were pulsed-labeled for the ﬁnal
5 h, and 1 Ci/200 l of [3H]-thymidine was  added to the culture
medium. At the end of incubation, the cells were collected in a
glass ﬁber ﬁlter (Packard) using a cell harvester (Filtermate 196,
Packard, Meriden, CT, USA) and allowed to dry for 24 h. Incorpora-
tion of radioactive thymidine was  determined by gas scintillation in
a direct beta counter (Packard). Cell counts were based on four inde-
pendent experiments, and the results (mean ± SD) were expressed
as percentage of the incorporation of the control (considered as
100%).
Cell cycle analysis – ﬂow cytometry
Flow cytometry analysis of DNA content was performed to
assess the cell cycle phase distribution in control conditions (0.5%
DMSO) or after ﬂavonoids casticin or penduletin (50 M) was
added to logarithmically growing GL-15 cells. After 48 h expo-
sure, GL-15 cells were harvested by trypsinization, ﬁxed with cold
ethanol and stained with propidium iodide (Biosource, Camarillo,
CA). Flow cytometry was  performed on a BD FACS Calibur. The
software BD Cell QuestTM Pro was  used to generate histograms
and determine the cell cycle phase distribution. Experiments were
performed at least three times.
Apoptosis detection – Annexin-V analysis and chromatin staining
Apoptosis was detected by monitoring the phosphatidylse-
rine externalization using an Annexin-V Cy3/6-carboxyﬂuorescein
diacetate (6-CFDA) staining kit (Sigma–Aldrich, St. Louis, MO). 6-
CFDA is used to measure viability; upon entering living cells, this
non-ﬂuorescent compound is hydrolyzed by the esterases present,
producing the ﬂuorescent compound 6-carboxyﬂuorescein (6-CF).
Treated and non-treated cells were cultured for 24 h in Plates
40 mm  in diameter (1.5 × 105 cells/plate). The cells were stained
with 100 l of binding buffer containing Annexin V-FITC (1 g/ml),
6-CFDA (500 M),  dH2O and binding buffer (100 mM HEPES/NaOH,
pH 7.5; 1.4 M NaCl; 25 mM CaCL2), as per the kit recommendations.
After 15 min  of incubation at room temperature in the dark, cells
were analyzed using a ﬂuorescence microscope (Olympus BX-2),
and images were recorded using a Variocam digital camera (PCO,
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ermany) connected to a personal computer. At least ten ﬁelds
ere analyzed and recorded, and the proportion of Annexin V/6-CF
ositive cells (referring to apoptosis) was determined. The apopto-
is of GL-15 cells was also determined by the ﬂuorescent dye Hoecht
3342 staining (Sigma–Aldrich, St. Louis, MO), which allows for
he determination and quantiﬁcation of the cells with fragmented
nd condensed nuclear chromatin. Control and treated cells seeded
n 40 mm polystyrene culture plates (1.5 × 105 cells/plate) were
insed three times with PBS and ﬁxed with cold methanol at −20 ◦C
or 10 min. Chromatin was stained with Hoecht 33258 (5 g/ml in
BS) for 10 min  at room temperature in a dark chamber. Thereafter,
ells were analyzed using an epiﬂuorescent microscope (Olympus
X-2), and images were recorded using a Variocam digital camera
PCO, Germany) connected to a personal computer. Ten random-
zed representative ﬁelds were analyzed each time. The proportion
f fragmented nuclei stained with Hoecht 33258 was determined
n 10 microscopic ﬁelds for each experimental point.
ragmentation and nuclear condensation – chromatin staining by
oecht-33258
The apoptosis of GL-15 cells was also determined by Hoecht-
3258 staining (Sigma–Aldrich, St. Louis, USA), which allows for
he determination and quantiﬁcation of cells with fragmented and
ondensed chromatin. After washing with PBS, GL-15 cells cul-
ured on 40-mm plates (1.5 × 105 cells/plate) were ﬁxed for 10 min
ith methanol and stored at −20 ◦C for 20 min. Subsequently, ﬁxed
ells were stained with the ﬂuorescent dye Hoecht-33258 at a ﬁnal
oncentration of 5 g/ml in PBS for 10 min  in a dark chamber at
oom temperature. The cells were then washed with PBS, and the
lates were analyzed by ﬂuorescent microscopy (Olympus AX70)
nd photographed. The apoptotic index represents the percentage
f fragmented nuclei and was determined in a microscopic ﬁeld of
t least 100 cells/experimental point.
NA fragmentation – comet assay
DNA integrity and single-strand breaks were monitored using
ingle-cell gel electrophoresis (comet assay) performed under
lkaline conditions based on a slightly modiﬁed version of the pro-
edure described by Ribeiro et al. Brieﬂy, all control and treated cells
eeded on 40-mm polystyrene plates (1.5 × 105 cells/plate) were
ncubated for 24 or 72 h in the presence of ﬂavonoids, with 0.5%
MSO as a negative control or 1 h direct exposure to UV light as a
ositive control. After treatment, the cells were scraped at 4 ◦C and
entrifuged at 1000 × g for 10 min. The pellet was diluted in 150 l
f PBS. A total of 30 l of the cell suspension was mixed with 300 l
% (w/v) low-melting-point agarose (Sigma–Aldrich), applied to
he surface of a normal-melting-point agarose pre-coated slide to
orm a microgel, and allowed to set for 5 min  at −20 ◦C. Microgels
ere submerged in cell lysis buffer (14.61% NaCl, 3.72% EDTA, 0.12%
ris, pH 10.1%, Triton X-100, 10% DMSO) for one h at 4 ◦C, protected
rom light. Following cell lysis, all slides were washed with PBS
or 10 min  to remove salt and detergent from the microgel. The
lides were placed in a horizontal electrophoresis unit and were
llowed to equilibrate for 20 min  with an electrophoresis buffer
0.034% EDTA; 0.3 N NaOH, pH 13). Electrophoresis was performed
or 25 min  at 0.13 A and 25 V. Slides were rinsed with neutralization
olution (12.12% Tris HCl, pH 7.5) three times for 5 min  each time,
xed with 100% ethanol, air-dried, and stored in a light-protected
ocation until analysis. For analysis and scoring, the DNA in the
omet slides microgels was stained with 0.1% ethidium bromide
25 l) for 5 min, and coverslips were applied before image analy-
is. The comet-assay samples were analyzed at 200× magniﬁcation
sing an epiﬂuorescent microscope (Olympus BX-2) and a rho-
amine ﬁlter. Three replicate experiments were performed with Farmacognosia 26 (2016) 34–43
two slides per experiment and a UV irradiation point. The image of
the electrophoresed DNA looks like a comet, with undamaged DNA
as the head and fragmented, migrating DNA forming the tail. Comet
images were recorded using a Variocam digital camera (PCO, Ger-
many) connected to a personal computer. Two  hundred randomly
selected cells were scored from each slide (two slides per dose),
and the percentage of comet cells (comet rate) was calculated. Tail
length (comet length) of 100 randomly selected comet cells was
also measured using a calibrated scale in the microscope’s ocular to
evaluate the distance of DNA migration using the software ImageJ
1.33u (Wayne Rasband, National Institutes of Health, USA).
Phenotypic analysis – Rosenfeld’s staining
Morphological changes were primarily assessed by analysis of
the Rosenfeld’s staining. All control and treated cells seeded on
40-mm polystyrene plates (1.5 × 105 cells/plate) were rinsed three
times with PBS (without Ca2+ and Mg2+) and ﬁxed for 10 min  with
methanol at −20 ◦C. Fixed cells were stained according to the proto-
col established by Rosenfeld (Rosenfeld, 1947). Rosenfeld’s reagent
(1 ml)  was added to the plates, which were then incubated for
20 min  at room temperature. Thereafter, the plates were rinsed
with water, air-dried, analyzed in an optic phase microscope (Nikon
TS-100) and photographed using a digital camera (Nikon E-4300).
Morphological changes – immunocytochemistry
Morphological changes were studied by immunocytochemistry
for the cytoskeletal protein vimentin. Control and treated cells
were rinsed three times with PBS and ﬁxed with cold methanol
at −20 ◦C for 10 min. The cells were incubated with mouse mono-
clonal anti-vimentin (1/500, clone V9, Boehringer, Mannheim) for
2 h and tetramethylrhodamine isothiocyanate conjugated sheep
anti-mouse (1/250, Biomarker, Israel) antibodies for 60 min  at
room temperature under slow agitation. Chromatin integrity or
nuclear fragmentation/condensation was  assessed by co-staining
the nuclear chromatin of ﬁxed cells for 10 min  with the ﬂuorescent
dye Hoecht-33258 (Sigma, St. Louis, MO)  at a ﬁnal concentra-
tion of 5 g/ml in PBS in a dark chamber at room temperature.
Thereafter, the cells were analyzed by ﬂuorescent microscopy and
photographed (Olympus AX70).
Statistical analysis
Results are expressed as the mean ± standard deviation. One-
way ANOVA test followed by a Student–Newman–Keuls test was
used to determine the signiﬁcant differences among groups that
differ by only one parameter. Values of p < 0.05 were considered
signiﬁcant.
Results
Effects on cell viability and growth
To determine sensitivity of the GL-15 cells of the ﬂavonoids
casticin, penduletin, and 5-hydroxy-7,4′-dimethoxyﬂavone, we
conducted the MTT  test that establishes cell viability by
measuring the functionality of mitochondrial dehydrogenases.
Compared to the control (0.5% DMSO), neither 5-hydroxy-7,4′-
dimethoxyﬂavone nor casticin showed toxicity to GL-15 cells after
24 h of exposure at any of the concentrations tested (1–100 M)
(Fig. 1A and B), only observed after 72 h treatment with 100 M
casticin. However, penduletin demonstrated toxicity beginning at
a concentration of 10 M.  These effects were also evident after
72 h of exposure and demonstrated the greater sensitivity of the
glioblastoma cell line GL-15 to penduletin.
P.L.C. Coelho et al. / Revista Brasileira de Farmacognosia 26 (2016) 34–43 37
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Fig. 1. Analysis metabolic activity by MTT  test in GL-15 cells exposed to 5-hydroxy-
7,4′-dimethoxyﬂavone, casticin, and penduletin at concentrations of 10, 50 and
100 M.  (A) GL-15 cells after 24 h exposure to ﬂavonoids. (B) GL-15 cells after 72 h
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Fig. 2. Analysis of cell proliferation by 3H-thymidine incorporation into the
DNA of GL-15 cells exposed to different concentrations of 5-hydroxy-7,4′-
dimethoxyﬂavone, casticin, and penduletin at concentrations of 10, 50 and 100 M.
(A) Results after 24 h of exposure to ﬂavonoids. (B) Results after 72 h of exposure toxposure to ﬂavonoids. Cells under control conditions were treated with 0.5% DMSO,
 vehicle for dilution of drugs. Results expressed in percentage in relation to the
ontrol, taken as 100% (*p < 0.05).
Because ﬂavonoids casticin and penduletin displayed both
eductions on viability and growth inhibition of GL-15 cells since
4 h after treatment, we analyzed the cell cycle distribution by ﬂow
ytometry. In control conditions, the proportion of GL-15 cells in
he G1 phase increased with time with a concomitant decrease in
 phase (Fig. 2). However, after 48 h exposure to 50 M ﬂavonoids
hanges in the cell cycle distribution were observed, and cells accu-
ulated in the G2 phase.
ffects on proliferation GL-15 cells
The effect on cell proliferation was studied by the incor-
oration of 3H-thymidine. The treatment of exponentially
ividing GL-15 cells with casticin, penduletin, and 5-hydroxy-
,4′-dimethoxyﬂavone induced a strong, dose-dependent growth
nhibition, with penduletin proving to be the most potent ﬂavonoid.
rowth inhibition occurred with values ranging from 78 to 95%
fter 24 h of exposure and was also evident after 72 h of exposure
Fig. 2A and B).
Because ﬂavonoids casticin and penduletin displayed an
nhibitory effect on GL-15 cell growth, we analyzed the cell cycle
istribution after treatment by ﬂow cytometry. In control condi-
ions, the proportion of GL-15 cells in the G0/G1 phase increased
ith time with a concomitant decrease in S phase (Fig. 3A).
lavonoids induced changes in the cell cycle distribution after 48 h
xposure. In the cultures exposed to 50 M castin the proportionﬂavonoids. Cells under control conditions were treated with 0.5% DMSO, a vehicle
for  dilution of the ﬂavonoids. Results expressed were in percentage in relation to
the  control, taken as 100% (*p < 0.05).
of cells in G0/G1 phase was  reduced with and concomitant increase
in proportion of cells in S phase. Moreover, a drastic reduction in
proportion of cells in G0/G1 phase was evident after penduletin
treatment, and cells accumulated in the S and G2  phase.
Induction of morphological changes
The induction of morphological changes of 5-hydroxy-7,4′-
dimethoxyﬂavone, casticin, and penduletin on GL-15 cells was
analyzed by microscopy after staining cells with Rosenfeld’s dye
(Fig. 4) and after performing immunocytochemistry for the inter-
mediate ﬁlament protein vimentin. Under control conditions,
GL-15 cells form a monolayer and the cells present a bipolar
phenotype. However, exposure of the cells to 100 M of 5-hydroxy-
7,4′-dimethoxyﬂavone, casticin and penduletin induced signiﬁcant
morphological changes beginning 24 h after treatment. A reduction
in the number of adhered cells was  observed in cultures exposed
to 100 M ﬂavonoids. The GL-15 cells exposed to 5-hydroxy-7,4′-
dimethoxyﬂavone showed a bipolar phenotype and a retracted
38 P.L.C. Coelho et al. / Revista Brasileira de
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Fig. 3. Analysis by ﬂow cytometry of cell cycle distributions of GL-15 cells in con-
trol conditions and exposed to different concentrations of casticin and penduletin
at concentration of 50 M,  after a 48 h experiment. The DNA content is shown by
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ytoplasm with tight, thin extensions. Furthermore, in cultured
ells treated with casticin or penduletin, there was  a dramatic
eduction in adherent cells and the remaining cells showed an
rregular phenotype and a distended cell body that was occasion-
lly accompanied by thick ﬁlaments and branching projections.
his effect was more intense in cultures treated with 100 M
avonoids and after 72 h of treatment. Morphological changes were
lso detected in GL-15 cells by immunolabeling the cytoskeletal
rotein vimentin (Fig. 5). We  observed that GL-15 cells express the
imentin protein homogenously and that it is distributed in the
ytoplasm, where it forms intermediate ﬁlaments. However, when
he cells were exposed to ﬂavonoids from C. betulaster,  they altered
he pattern of protein distribution, which was more diffuse in the
ytoplasm following phenotypic changes.
poptosis detectionThe ability to induce programmed cell death of the ﬂavonoids
xtracted from C. betulaster was initially determined in situ with
nnexin-V, which detects phosphatidylserine residues in the Farmacognosia 26 (2016) 34–43
outlet of membranes, and with CFDA dye, an indicator of viable
cells. Twenty-four hours after treatment, cells treated with 100 M
ﬂavonoids demonstrated a signiﬁcant increase in the proportion of
Annexin-V positive cells, thus indicating that apoptosis occurred
(Fig. 6A–E).
Induction of apoptosis in GL-15 cells was also investigated by
nuclear chromatin staining with the DNA intercalating dye Hoecht-
33258 (Fig. 7A–E). Microscopy with ultraviolet radiation revealed
that after 72 h of exposure to 100 M ﬂavonoids, 30–40% of the
remaining adherent cells demonstrated nuclear condensation and
chromatin fragmentation, which are features of apoptosis. These
characteristics were not observed in cells under control conditions.
The comet test, which identiﬁes fragmentation of genetic mate-
rial individually in cells, was then performed to investigate DNA
fragmentation level in GL-15 cells. We  observed that GL-15 cells
exposed to 10–100 M 5-hydroxy-7,4′-dimethoxyﬂavone, casticin,
and penduletin demonstrated DNA fragmentation after 72 h of
treatment (Fig. 8). The highest comet rates were observed after
exposure to 100 M ﬂavonoids and were approximately 10.91% in
cells exposed to 5-hydroxy-7,4′-dimethoxyﬂavone, 8.65% in cells
exposed to casticin, and 21.21% in cells exposed to penduletin.
Among the ﬂavonoids studied, penduletin induced the most severe
fragmentation of chromatin with the highest comet rate. The ultra-
violet radiation, adopted as a positive control, caused lesions in
GL-15 cells with ratios of approximately 65% due to the wave-
length’s capability to generate free radicals that act directly on DNA
to induce damage (data not shown). A small proportion of GL-15
cells with the comet form (∼1.97%) was  observed in control cultures
treated with the solvent DMSO (0.5%). However, according to Tice
et al., the comet test has demonstrated sensitivity capable of detec-
ting DNA damage at very low levels, and these ﬁndings could inform
our experimental model or the experimental conditions adopted.
Discussion
The use of medicinal plants to treat diseases is a constant
practice among the Brazilian population and is most prevalent in
the Northeast region due to cultural inﬂuences. The use of in vitro
cell lines to investigate the biological activity of natural products
is one of the ﬁrst steps in the search for novel drugs (Yunes and
Calixto, 2001). In our study, we used the GL-15 cell line derived from
human multiforme glioblastoma as an experimental model (char-
acterized and established by Bocchini et al., 1993) to investigate
the antitumor activity of the ﬂavonoids casticin, 5-hydroxy-7,4′-
dimethoxyﬂavone and penduletin, which can be extracted from the
leaves of C. betulaster (Barbosa et al., 2003).
Initially, we  used the MTT  test to determine the effects of
ﬂavonoids on growth and cell viability by measuring the incorpora-
tion of 3H-thymidine into the DNA of GL-15 cells and the metabolic
activity after exposure to different concentrations of the different
ﬂavonoids. We  observed that all tested molecules inhibited cell
proliferation in a dose-dependent manner and interfered with the
mitochondrial function of GL-15 cells, thus reducing its viability.
Penduletin was the most potent ﬂavonoid, causing an inhibition of
proliferation and cell viability of approximately 50–60% after 24 h
of treatment at a concentration of 10 M.
Our studies also demonstrated that ﬂavonoids from C. betulaster
induced programmed cell death in GL-15 cells, shown by label-
ing externalized phosphatidylserine residues in the cell membrane
by Annexin V, a primary event of the apoptotic process (Jellinger,
2006; Greene et al., 2007). Flavonoid-induced apoptosis was also
determined by identiﬁcation of characteristics of cells undergoing
apoptosis, such as nuclear condensation, as determined by the DNA
intercalant dye Hoecht 33258, and DNA fragmentation, as deter-
mined by the comet test (Benkovic et al., 2008). These ﬁndings
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emonstrate that the ﬂavonoids tested herein can reduce prolifer-
tion and alter the metabolism of the glioblastoma cell line GL-15
nd can also induce apoptosis, all of which are essential activities
n the screening of drugs for tumor treatment.
Several studies have shown ﬂavonoids as active principles
esponsible for various biological effects, including antitumor activ-
ty (Middleton et al., 2000). As demonstrated by Scheck et al.
ig. 5. Morphological analysis by immunocytochemistry for the cytoskeletal protein vime
ith  100 M ﬂavonoids from C. betulaster,  (B) 5-hydroxy-7,4′-dimethoxyﬂavone, (C) castcontrol conditions (0.5% DMSO, A) or after 24 h, 48 h and 72 h exposure to 100 M
), or penduletin (K, L, M).  Objective 20×. Scale = 100 m.
(2006), the extract from Scutelaria baicalenses containing ﬂavonoids
inhibits dose-dependent effects on the viability of human glioblas-
toma cells and induces growth inhibition and apoptosis. Ferguson
et al. (2006) also showed that ﬂavonoids present in Vaccinia
macrocarpa inhibit cell proliferation, cause cell cycle arrest, and
induce apoptosis in the human glioblastoma cell line U87. More-
over, Braganhol et al. (2006) showed that the ﬂavonoid quercetin
ntin in GL-15 cells (A) under control conditions (0.5% DMSO) or after 72 h treatment
icin, or (D) penduletin. Object 20×.  Scale = 100 m.
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C.  betulaster by marking with Annexin V/CFDA. (A) 0.5% DMSO, (B) 5-hydroxy-7,4′-dimethoxyﬂavone, (C) casticin, or (D) penduletin. The photomicrograph represents the
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nhibits cell proliferation in the glioblastoma multiforme cell line
138MG, thus inhibiting cell viability and the induction of apopto-
is. Together with our results, these ﬁndings suggest that ﬂavonoids
re promising supplementary molecules for developing new treat-
ents for malignant gliomas.
The inhibitory effect of ﬂavonoids has also been found in other
ypes of tumor cells. Roy et al. (2007) demonstrated in vitro that the
avonoid baicalein inhibits the proliferation of tumor cells of colon
HT-29) and prostate cancer (DU-145). Ye et al. (2007) demon-
trated that the ﬂavonoid extracted from Cleistocalyx operculatus
nduces the inhibition of metabolic activity and apoptosis in lung
ancer (SMMC-7721), pancreatic cancer (8898), chronic leukemia
K562), uterine cervical cancer (HeLa) and lung cancer (95-D) cell
ineages.
Rosenfeld’s staining was used to demonstrate the ability of
avonoids from C. betulaster to induce morphological changes in
L-15 cells. We  observed that all the ﬂavonoids tested induced
orphological changes. The GL-15 cells exposed to 5-hydroxy-
,4′-dimethoxyﬂavone demonstrated cell body retraction and
lamentous extension formation. However, in the presence of
asticin and penduletin, GL-15 cells had enlarged cells bodies
nd a polygonal phenotype with short, ﬁne extensions. These
orphological changes in GL-15 cells were also detected by
mmunolabeling vimentin. Vimentin is a cytoskeletal protein that
s part of the intermediate ﬁlament of immature cells. Immuno-
ytochemical analyses with GL-15 cells conducted by Bocchini
t al. combined with the observations of this and other studies
ave revealed that these cells constitutively express the protein
imentin and exhibit a homogeneous distribution in all cell bodies,red) positive cells. Object 20×.  Scale = 100 m.  (E) Quantiﬁcation of Annexin-V/CFDA
contributing to the cell’s bipolar phenotype. Our results showed
that ﬂavonoids from C. betulaster are able to induce phenotypical
changes in GL-15 glioblastoma cells, suggesting that a morphogenic
potential that may  be investigated using markers of different cell
populations in the CNS. The morphogenic potential of casticin was
already evidenced in the primary cultures of rat cortical neurons
(Sampaio-Spohr et al., 2010). Research carried out by Xie et al.
(2005) has conﬁrmed that polyphenolic compounds are able to
induce morphological changes and programmed cell death in lung
cancer cells. In fact, in a previous study, we observed that the
ﬂavonoid rutin induced astrocytic differentiation in GL-15 cells
(Santos et al., 2011).
A study by Haidara et al. (2006), suggested that the ﬂavonoid
casticin may  be important to anti-cancer therapy, due to its inhi-
bition of the in vitro proliferation of the epidermal carcinoma
cell line. Kobayakawa et al. (2004) administered casticin to arrest
the cell cycle in the G2-M phase in lung cancer and colon car-
cinoma cell lineages, thus conﬁrming this ﬂavonoid’s important
antitumor activity. A study conducted by Li et al. (2005) dis-
closed that penduletin demonstrates antitumoral activity with
breast cancer cells. However, the biological activity of 5-hydroxy-
7,4′-dimethoxyﬂavone has been not yet been explored. Research
conducted by El-Ghorab et al. (2003) demonstrated that this
ﬂavonoid has antioxidant activity. Studies conducted by Wang et al.
(1992) and Martini et al. (2004) have shown that 5-hydroxy-7,4′-
dimethoxyﬂavone has signiﬁcant antibacterial activity.
Even inhibitory and morphogenic effects were observed in
our experimental procedures for all ﬂavonoids tested; the GL-
15 cells of the ﬂavonoid tested presented distinct patterns of
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ragmentation under control conditions or after 72 h treatment with 100 M ﬂavon
esponse intensities and of phenotypic changes in function. These
avonoids have different amounts of hydroxyl and methyl groups
n their structures. Several studies have shown this to be an
mportant feature, as the degree of hydroxylation and methyl-
tion favored an increase or decrease in the potential actions,
espectively. Of the ﬂavonoids used in our experiments, 5-
ydroxy-7,4′-dimethoxyﬂavone was clearly the least effective, and
asticin (5,3′-dihydroxy-3,6,7,4′-tetramethoxyﬂavone) and pen-
uletin (5,4′-dihydroxy-3,6,7-trimethoxyﬂavone) were the most
ffective. These ﬁndings suggest that the number of hydroxyl and
ethyl groups is essential to activity of ﬂavonoids in GL-15 glioblas-oma cells.
According Sathornsumetee and Rich (2007), gliomas have
 high recurrence and are the most aggressive tumor in the 20×,  (D) quantiﬁcation of cells presenting nuclear chromatin condensation and/or
CNS. However, the conventional treatment associated with anti-
angiogenesis therapy can reduce the rate of tumor recurrence,
improving patient survival. In a literature review, Gerstner et al.
examined the same issue, reporting the results of clinical trials
conducted with patients using conventional therapy and inhibitory
molecules of growth factors to improve patient survival. Therefore,
compounds that show antitumor activity may  be a key factor for
the improvement of the conventional treatment of CNS tumors.
The C. betulaster ﬂavonoids tested in our study demonstrated
biological activity against the human malignant glioblastoma
cell line GL-15, presenting basic properties such as proliferation
inhibition and apoptosis induction. Penduletin proved to be the
most potent ﬂavonoid, and this study suggests that ﬂavonoids may
be promising supplementary drugs for glioblastoma treatment.
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